Severe Combined Immunodeficiency (SCID)
Gene or Region: DNAPK
Reference Variant: TCTCA
Mutant Variant: -
Affected Breeds: Arabian
Research Confidence: High - Findings reproduced in multiple studies
Explanation of Results: scid/scid = homozygous for Severe Combined Immunodeficiency, trait expressed scid/n = heterozygous for Severe Combined Immunodeficiency, carrier n/n = no variant detected
General Information
Severe combined immunodeficiency disease is a condition in which the foal has essentially no immune system, due to a complete absence of certain types of immune cells, specifically B and T lymphocytes. Affected foals are unable to mount an effective immune response after infection and are unable to recover from infections that unaffected foals would easily resist. The disease is universally fatal in horses, usually within 4-6 months of life. It is a recessive trait, meaning that it requires two mutant alleles to manifest; animals carrying just one copy of the mutant allele are completely healthy and are “carriers”, meaning that they can pass the mutation to their offspring. If two carrier horses mate, there is a 25% chance that the foal will have SCID. It has only been detected in horses of Arabian descent, and studies have determined that ~8% of Arabian horses are carriers of the SCID allele.
The particular mutation assessed is a five-nucleotide deletion within the DNAPK gene, leading to a mutant form of the DNA-PK protein that is non-functional. DNA-PK is involved in a process called V(D)J recombination, which leads the development of mature B and T lymphocytes. All known cases of horse SCID arise from this mutation.
References
Ding et al., DNA-PKcs mutations in dogs and horses: allele frequency and association with neoplasia.” (2002) Gene 283: 263-9. PMID: 11867233
Bernoco, D and Bailey, E, “Frequency of the SCID gene among Arabian horses in the USA.” (1998) Animal Genetics 29: 41-42. PMID: 9682449
Shin et al., “A Kinase-Negative Mutation of DNA-PKcs in Equine SCID Results in Defective Coding and Signal Joint Formation.” (1997) Journal of Immunology 158: 3565-9. PMID: 9103416
More Horse Health
Lavender Foal Syndrome
Lavender foal syndrome (LFS), also known as coat color dilution lethal, is a neurological dysfunction in newborn foals. Symptoms are apparent at birth and include seizures, severe hyper-extension of limbs, neck and back, stiff paddling leg movements, involuntary eye movement and inability to stand or sit upright. The coat usually has a dilute color that ranges in shade from silver to a pale lavender/pink. As there is no treatment, affected foals are humanely euthanized.
Lordosis
Lordosis (L1, L2, L3, L4), also known as "Swayback", is a curvature or dip in the spine that is often seen in older horses. However, in the American Saddlebred, this condition also affects younger horses. These animals do not appear to experience pain from their condition and are still able to be used under saddle.
Malignant Hyperthermia
Malignant hyperthermia (MH) is a muscle disorder in which anesthesia, stress, or extreme exercise trigger a hyperthermic state. Symptoms include high temperature, increased heart rate, high blood pressure, sweating, acidosis, and muscle rigidity. If symptoms are not immediately resolved, death is likely to occur.
Myosin-Heavy Chain Myopathy
Myosin-Heavy Chain Myopathy (MY; previously "IMM") is a genetic muscle disease found most commonly in stock-type horses that can result in two different presentations, Immune-Mediated Myositis (IMM) and Nonexertional Rhabdomyolysis “tying up,” which are both characterized by muscle damage or loss. Both presentations are associated with the same genetic variant. Horses with MYHM may exhibit one or both presentations at different times in their lives, although some horses carrying the variant might not display any symptoms at all.